Sire Bioscience Announces New CEO to Drive Company Vision in 2020 and Beyond

ID: 1554354
recent pressrelease next pressrelease

(businesspress24) - TORONTO, Ontario, November 29, 2019 - Sire Bioscience Inc. (CSE:SIRE) (OTC:BLLXF) (FSE:BR1B) (Sire or the Company) is pleased to announce that Brian Polla, the Companys Founder and current COO and director, has been appointed as the new CEO of the Company, effective immediately.

Mr. Polla is a successful entrepreneur with over 20 years of business management experience and capital market expertise. Over the years, Mr. Polla has developed an extensive background in the health and wellness sector. As SIREs founding member, Mr. Polla has been working tirelessly behind the scenes to bring the Companys vision to life. Upon stepping into the CEO role, his immediate focus will be on improving shareholder value.

We are always pushing to accelerate our efforts to drive long-term, sustainable shareholder value, says Mr. Polla, one way that we will do this is through our House of Brands strategy which will provide customized products for unique consumer experiences. We will also tap into our teams extensive CPG background to create thriving brands.

To facilitate the change in management, Jeff Zanini will be stepping down as the CEO and a director but will remain a strategic advisor to SIRE. The Companys board of directors sincerely thanks him for his contribution and leadership, and wishes him the best in his future endeavours.

About Sire Bioscience

Sires principal business activity is to engage in the investment, production of, and sale of hemp. Its mission is to offer people a way to connect with themselves, with others, and with the world around them.

SIRE is headquartered in Toronto, Ontario and is backed by a group of successful entrepreneurs who have extensive experience in the areas of manufacturing, logistics, and renewable energy. It has secured a state-of-the-art agricultural facility in Leamington, Ontario - a preeminent locale for hemp cultivation in Canada.

FOR INFORMATION, CONTACT:



Sire Bioscience Inc.
E: ir(at)sirebioscience.com

213 Sterling Road, Suite 206
Toronto, ON M6R 2B2
Canada
Ph: (416) 262-0871
Email: ir(at)sirebioscience.com
www.sirebioscience.com

The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release.

Forward-Looking Information Cautionary Statement

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release. Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer''s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.




More information:
http://



Keywords (optional):



Company information / Profile:

PressRelease by

Requests:





PressContact / Agency:



published by: irw
print pressrelease  send to a friend  

Date: 11/29/2019 - 09:01
Language: English
News-ID 1554354
Character count: 3095
Kontakt-Informationen:
Firma: Sire Bioscience Inc.
Ansprechpartner: Feedback to businesspress24.com about Pressrelease-id:
Stadt: Wien
Telefon:

Meldungsart:
Versandart:
Freigabedatum:
Comments:



Number of hits: 351

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 9 432
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 81


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.